ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH BIORESORBABLE VASCULAR SCAFFOLDS ABSORB (BVS) IN COMPARISON WITH MODERN DRUG-ELUTING STENTS (DES)
Journal Title: World Journal of Pharmaceutical and Medical Research - Year 2019, Vol 5, Issue 2
Abstract
200 patients with СHD were examined. The study found that in the acute form of the disease, the indicators of quality of life (QOL) responsible for physical health were slightly worse than in chronic ischemic heart disease. In dynamics, an improvement in all grades of the SF-36 scale was noted. Depending on the type of implants are no significant differences in QoL scale was not detected (all p> 0.05).
Authors and Affiliations
Yuldashev N. P.
Keywords
Related Articles
- EP ID EP675269
- DOI -
- Views 161
- Downloads 0
BIOCHEMICAL EFFECTS OF ETHANOL LEAF EXTRACT OF MIMOSA PUDICA IN THIOACETAMIDE-INDUCED HEPATIC AND NEPHROTIC INJURY IN RATS
The study was to investigate the biochemical effect of ethanol extract of Mimosa pudica leaf in thioacetamide-induced albino rats by using liver and kidney serum marker enzymes. After the treatment scheduled period of 21...
STUDY OF TETANUS CASES IN INTENSIVE CARE UNIT OF PEDIATRICS
Objective: To study the demographic and clinical features, outcome, complications and treatment cost of tetanus patients admitted in Paediatirc Intensive Care Unit of Benazir Bhutto hospital Rawalpindi. Methods: It is a...
HIPPOCRATIC CONCEPT OF TUMORS "A SOURCE STUDY"
The aim of this study is to evaluate Theories related to etiology of different Tumors and their natures in Hippocratic Corpus as their relation to what modern and advanced medicine found.
FACTORS AFFECTING STEREO-ACUITY IN ACCOMMODATIVE ESOTROPIA
Objective: To determine the prognostic factors affecting stereoacuity in patients with refractive accommodative esotropia (RAE) according to the results of long follow- up period. Methods: We reviewed the charts of 70 pa...
CARDIOVASCULAR OUTCOME TRIALS IN TYPE 2 DIABETES: RELIABLE OR BIASED!
Several recent multinational clinical trials have suggested improvement in cardiovascular outcomes with antihyperglycemic agents in subjects with type 2 diabetes.[1-4] First and foremost, the designs implemented in these...